A recent clinical trial in RA, reported that the administration of umbilical cord blood MSCs resulted in the reduction DAS28 score and peripheral inflammatory parameters, including TNF-α, IL-1β, IL-6 and IL-8, accompanied by the increase of IL-10 expression. The gene discussed is IL6; the disease is rheumatoid arthritis.